National Health Investors... (NHI)
NYSE: NHI
· Real-Time Price · USD
78.05
-0.43 (-0.55%)
At close: Sep 10, 2025, 3:59 PM
78.05
0.00%
After-hours: Sep 10, 2025, 04:24 PM EDT
National Health Investors Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Senior Housing Operating Portfolio Revenue | 14.22M | 13.94M | 27.39M | 13.77M | 13.39M | 68.13M | 66.44M | 67.59M | 66.03M | 70.61M | 58.79M | 64.21M | 47.81M |
| Senior Housing Operating Portfolio Revenue Growth | +1.99% | -49.12% | +98.93% | +2.85% | -80.35% | +2.54% | -1.70% | +2.36% | -6.48% | +20.11% | -8.45% | +34.32% | n/a |
| Real Estate Investment Segment Revenue | 76.41M | 75.31M | 143.1M | 69.06M | 71.5M | 13.26M | 12.95M | 12.37M | 11.79M | 11.7M | 11.79M | 12.01M | 11.99M |
| Real Estate Investment Segment Revenue Growth | +1.45% | -47.37% | +107.21% | -3.42% | +439.41% | +2.37% | +4.71% | +4.87% | +0.79% | -0.77% | -1.85% | +0.18% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.13M | 8.26M | 5.83M | 5.05M | 5.04M | 5.88M | 5.07M | 4.5M | 4.48M | 5.78M | 5.18M | 4.83M | 5.39M | 9.93M | 3.9M | 3.77M | 3.55M | 8.12M | 3.6M | 3.03M | 3.28M | 4.64M | 3.71M | 2.84M | 3.07M | 4.28M | 2.42M | 3.16M | 2.99M | 4.28M | 3.15M | 2.73M | 2.67M | 4.16M | 2.57M | 2.33M | 2.24M | 3.06M | 2.64M | 1.81M | 2.59M | 3.95M |
| Selling, General, and Administrative Revenue Growth | -25.80% | +41.62% | +15.43% | +0.30% | -14.34% | +16.01% | +12.68% | +0.38% | -22.42% | +11.57% | +7.12% | -10.32% | -45.73% | +154.37% | +3.61% | +6.17% | -56.30% | +125.34% | +19.07% | -7.80% | -29.34% | +25.24% | +30.51% | -7.46% | -28.31% | +76.88% | -23.45% | +5.89% | -30.20% | +35.82% | +15.54% | +2.29% | -35.95% | +62.02% | +10.54% | +3.61% | -26.55% | +15.81% | +45.91% | -30.17% | -34.44% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |